LifeBond Nets $20M Funding
Biosurgery device company LifeBond has lured $20 million in a Series C round with investors Giza Capital and Aurum Ventures, with Johnson & Johnson Development Corp. participating in the round as well. Other investors in the Israel-based company include Pitango Venture Capital, and the Sitelman Group.
8 August 2011•2 mins read
